Clinical Trial: A Phase 3 Clinical Study of SHR-A1912 Combined With R-GemOx Versus R-GemOx in Diffuse Large B-cell Lymphoma

U.S., April 17 -- ClinicalTrials.gov registry received information related to the study (NCT06929624) titled 'A Phase 3 Clinical Study of SHR-A1912 Combined With R-GemOx Versus R-GemOx in Diffuse Large B-cell Lymphoma' on April 08.

Brief Summary: This is a multicenter, randomized, open-label, phase 3 clinical study to evaluate the efficacy of SHR-A1912 combined with R-GemOx in relapsed refractory diffuse large B-cell lymphoma.

Study Start Date: April, 2025

Study Type: INTERVENTIONAL

Condition: Diffuse Large B-cell Lymphoma

Intervention: DRUG: SHR-A1912 Injection

SHR-A1912 injection.

DRUG: Rituximab Injection

Rituximab injection.

DRUG: Gemcitabine Hydrochloride for Injection

Gemcitabine hydrochloride for injection.

DRUG: Oxalipl...